Continuous 4-week ECG monitoring with adhesive electrodes reveals AF in patients with recent embolic stroke of undetermined source.
atrial fibrillation
electrocardiogram
embolic stroke of undetermined source
stroke
Journal
Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc
ISSN: 1542-474X
Titre abrégé: Ann Noninvasive Electrocardiol
Pays: United States
ID NLM: 9607443
Informations de publication
Date de publication:
09 2019
09 2019
Historique:
received:
28
02
2019
accepted:
13
03
2019
pubmed:
3
5
2019
medline:
5
8
2020
entrez:
3
5
2019
Statut:
ppublish
Résumé
Atrial fibrillation (AF) frequently escapes routine stroke workup due to its unpredictable and often asymptomatic nature, leaving a significant portion of patients at high risk of recurrent stroke. Recent trials emphasized continuous electrocardiogram (ECG) monitoring in the detection of occult AF. We screened AF in patients meeting the embolic stroke of unknown source (ESUS) criteria using an external miniaturized recorder with an adhesive electrode. Patients aged ≥50 with recent ESUS were prospectively screened and assigned to wear a 1-lead ECG device capable to record continuous ECG for up to 4 weeks. Electrodes were replaced every 3-4 days. Primary outcome was proportion of patients completing at least 80% of monitoring. Secondary outcome measures included incidence of AF and initiation of oral anticoagulation therapy after AF detection. Fifty-seven patients were monitored (mean age 64.5 ± 8.2 years, median delay from stroke to the start of monitoring 8 days, IQR 4-44). Of these, 51 patients (89.5%) completed at least 80% of the desired monitoring period. We detected AF ≥30 s in seven patients (12.3%), all of whom initiated anticoagulation therapy. Atrial fibrillation was revealed in six patients (85.7%) within the first week of monitoring. Compared to patients without AF, patients with AF were older (70.6 ± 5.1 vs. 63.6 ± 8.3 years, p < 0.011) and more obese (body mass index 30.0 ± 3.4 vs. 26.6 ± 4.6, p < 0.039). Prolonged ECG monitoring with an external device using adhesive electrodes is feasible in ESUS patients, since nine out of ten patients used the device appropriately and AF was detected in one out of eight patients.
Sections du résumé
BACKGROUND
Atrial fibrillation (AF) frequently escapes routine stroke workup due to its unpredictable and often asymptomatic nature, leaving a significant portion of patients at high risk of recurrent stroke. Recent trials emphasized continuous electrocardiogram (ECG) monitoring in the detection of occult AF. We screened AF in patients meeting the embolic stroke of unknown source (ESUS) criteria using an external miniaturized recorder with an adhesive electrode.
METHODS
Patients aged ≥50 with recent ESUS were prospectively screened and assigned to wear a 1-lead ECG device capable to record continuous ECG for up to 4 weeks. Electrodes were replaced every 3-4 days. Primary outcome was proportion of patients completing at least 80% of monitoring. Secondary outcome measures included incidence of AF and initiation of oral anticoagulation therapy after AF detection.
RESULTS
Fifty-seven patients were monitored (mean age 64.5 ± 8.2 years, median delay from stroke to the start of monitoring 8 days, IQR 4-44). Of these, 51 patients (89.5%) completed at least 80% of the desired monitoring period. We detected AF ≥30 s in seven patients (12.3%), all of whom initiated anticoagulation therapy. Atrial fibrillation was revealed in six patients (85.7%) within the first week of monitoring. Compared to patients without AF, patients with AF were older (70.6 ± 5.1 vs. 63.6 ± 8.3 years, p < 0.011) and more obese (body mass index 30.0 ± 3.4 vs. 26.6 ± 4.6, p < 0.039).
CONCLUSIONS
Prolonged ECG monitoring with an external device using adhesive electrodes is feasible in ESUS patients, since nine out of ten patients used the device appropriately and AF was detected in one out of eight patients.
Identifiants
pubmed: 31045315
doi: 10.1111/anec.12649
pmc: PMC6850068
doi:
Substances chimiques
Anticoagulants
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e12649Subventions
Organisme : Helsinki and Uusimaa Hospital District (TYH2016127 and TYH2017237)
Pays : International
Informations de copyright
© 2019 The Authors. Annals of Noninvasive Electrocardiology Published by Wiley Periodicals, Inc.
Références
Circulation. 2013 Jan 15;127(2):224-32
pubmed: 23212720
Ann Noninvasive Electrocardiol. 2019 Sep;24(5):e12649
pubmed: 31045315
Int J Stroke. 2017 Aug;12(6):589-596
pubmed: 28730948
Annu Int Conf IEEE Eng Med Biol Soc. 2012;2012:2440-3
pubmed: 23366418
Stroke. 2001 Feb;32(2):392-8
pubmed: 11157172
Parkinsonism Relat Disord. 2016 Dec;33:134-137
pubmed: 27697369
Lancet Neurol. 2018 Dec;17(12):1053-1060
pubmed: 30274772
Stroke. 1991 Aug;22(8):983-8
pubmed: 1866765
Intern Med J. 2018 Jun;48(6):661-667
pubmed: 29193638
Cerebrovasc Dis. 2010;30(4):410-7
pubmed: 20720410
Curr Treat Options Cardiovasc Med. 2016 Aug;18(8):52
pubmed: 27325256
Ann Noninvasive Electrocardiol. 2008 Jan;13(1):44-60
pubmed: 18234006
Stroke. 2017 Apr;48(4):867-872
pubmed: 28265016
Stroke. 2001 Dec 1;32(12):2735-40
pubmed: 11739965
N Engl J Med. 2014 Jun 26;370(26):2478-86
pubmed: 24963567
J Atr Fibrillation. 2015 Feb 28;7(5):1169
pubmed: 27957147
Ann Med. 2015;47(5):406-13
pubmed: 26224200
Thromb Haemost. 2017 Oct 5;117(10):1833-1835
pubmed: 28906543
J Stroke Cerebrovasc Dis. 2012 Apr;21(3):210-6
pubmed: 20727789
Pacing Clin Electrophysiol. 2013 Mar;36(3):328-33
pubmed: 23240827
N Engl J Med. 2014 Jun 26;370(26):2467-77
pubmed: 24963566
Lancet Neurol. 2017 Apr;16(4):282-290
pubmed: 28187920
Thromb Haemost. 2017 Oct 5;117(10):1962-1969
pubmed: 28862284
J Electrocardiol. 2012 Mar;45(2):148-53
pubmed: 22153334
Circulation. 2017 Mar 7;135(10):e146-e603
pubmed: 28122885
Lancet Neurol. 2015 Apr;14(4):377-87
pubmed: 25748102